These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 34281253)

  • 1. Perioperative Systemic Treatment for Muscle-Invasive Bladder Cancer: Current Evidence and Future Perspectives.
    Kim IH; Lee HJ
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the Bladder.
    Rouanne M; Bajorin DF; Hannan R; Galsky MD; Williams SB; Necchi A; Sharma P; Powles T
    Eur Urol Oncol; 2020 Dec; 3(6):728-738. PubMed ID: 33177001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer.
    Macleod LC; Yabes JG; Yu M; Fam MM; Hale NE; Turner RM; Lopa SH; Gingrich JR; Borza T; Skolarus TA; Davies BJ; Jacobs BL
    Urol Oncol; 2019 Jul; 37(7):462-469. PubMed ID: 31053530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative systemic therapy in muscle invasive bladder cancer: Current standard method, biomarkers and emerging strategies.
    Kim KH; Lee HW; Ha HK; Seo HK
    Investig Clin Urol; 2023 May; 64(3):202-218. PubMed ID: 37341001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative systemic therapy for bladder cancer.
    Eulitt PJ; Bjurlin MA; Milowsky MI
    Curr Opin Urol; 2019 May; 29(3):220-226. PubMed ID: 30855376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant and adjuvant treatments in muscle-invasive bladder cancer: Where are we?
    Osanto S; Álvarez Gómez de Segura C
    Arch Esp Urol; 2020 Dec; 73(10):971-985. PubMed ID: 33269716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immuno-oncological approaches in the perioperative therapy of muscle invasive bladder cancer].
    Schmid SC; Koll FJ; Beckert F; Seitz AK
    Urologe A; 2020 Jul; 59(7):790-796. PubMed ID: 32472221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Perioperative Therapy for Muscle Invasive Bladder Cancer.
    Ma J; Black PC
    Hematol Oncol Clin North Am; 2021 Jun; 35(3):495-511. PubMed ID: 33958147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative therapy for muscle invasive bladder cancer.
    Leow JJ; Fay AP; Mullane SA; Bellmunt J
    Hematol Oncol Clin North Am; 2015 Apr; 29(2):301-18, ix. PubMed ID: 25836936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review.
    Vashistha V; Quinn DI; Dorff TB; Daneshmand S
    BMC Cancer; 2014 Dec; 14():966. PubMed ID: 25515347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides.
    Reardon ZD; Patel SG; Zaid HB; Stimson CJ; Resnick MJ; Keegan KA; Barocas DA; Chang SS; Cookson MS
    Eur Urol; 2015 Jan; 67(1):165-170. PubMed ID: 24472710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy for bladder cancer.
    Sonpavde G; Lerner SP
    Oncology (Williston Park); 2007 Dec; 21(14):1673-81; discussion 1686-8, 1691, 1694. PubMed ID: 18247016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neoadjuvant, inductive or adjuvant chemotherapy of bladder cancer].
    Ohlmann CH; De Santis M
    Urologe A; 2013 Nov; 52(11):1534-8, 1540. PubMed ID: 24197083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer.
    McFerrin C; Davaro F; May A; Raza S; Siddiqui S; Hamilton Z
    Investig Clin Urol; 2020 Nov; 61(6):565-572. PubMed ID: 32985142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on perioperative systemic therapy for urothelial carcinoma.
    Rouvinov K; Plimack ER; Zibelman M; Ghatalia P; Geynisman DM
    Clin Adv Hematol Oncol; 2019 Mar; 17(3):176-183. PubMed ID: 30969956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Status of Perioperative Therapy in Muscle-Invasive Bladder Cancer and Future Directions.
    Cockrell DC; Rose TL
    Curr Oncol Rep; 2023 May; 25(5):511-520. PubMed ID: 36897554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy.
    Mazzone E; Nazzani S; Knipper S; Tian Z; Preisser F; Gallina A; Soulières D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Wisnivesky J; Karakiewicz PI
    Eur J Surg Oncol; 2019 Jul; 45(7):1253-1259. PubMed ID: 30755341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of Current and Future Adjuvant Therapy for Muscle-Invasive Urothelial Carcinoma.
    Nadal R; Apolo AB
    Curr Treat Options Oncol; 2018 May; 19(7):36. PubMed ID: 29808294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in perioperative combination therapy in muscle-invasive bladder cancer.
    Mellema JJ; van Rhijn BWG; van der Heijden MS
    Curr Opin Urol; 2023 Sep; 33(5):404-411. PubMed ID: 37265341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic, perioperative management of muscle-invasive bladder cancer and future horizons.
    Funt SA; Rosenberg JE
    Nat Rev Clin Oncol; 2017 Apr; 14(4):221-234. PubMed ID: 27874062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.